FindTrial
Sign In

A observational study to check the results of patients with COVID-19 infection treated with using high flow nasal cannula(using heat and humified delivered oxygen through nasal cannula)

A retrospective observational study to determine the outcomes of patients with COVID-19 treated with using HFNC(high flow nasal cannula)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/02/031424
Enrollment
50
Registered
2021-02-19
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: J00-J99- Diseases of the respiratory system

Interventions

None listed

Sponsors

Maharashtra medical research society
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Covid 19 positive adult patients treated with HFNC

Exclusion criteria

Exclusion criteria: Covid 19 negative patients.

Design outcomes

Primary

MeasureTime frame
The results of this study are expected to help understand the clinical and lab profile of patients with Covid-19 who were treated using HFNO and their outcomes interms of recovery ,requirement of invasive ventilation and mortalityTimepoint: It is a retrospective study.Approximately 4 days—

Secondary

MeasureTime frame
To help understand the efficacy of HFNC ,to avoid the need for mechanical ventilation and mortality outcomesTimepoint: It is a retrospective study.Follow up after 15-20 days on Out patient department basis.—

Countries

India

Contacts

Public ContactDr Narendra Javadekar

Ratna Memorial Hospital ,968,Senapati bapat road Pune 53

narenjavdekar@yahoo.co.in02025676861

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026